-+ 0.00%
-+ 0.00%
-+ 0.00%

Pluri Signed An Exclusive Collaboration Agreement With Hemafund, A Ukrainian Umbilical Cord Blood Bank With Clinical And Research Laboratories And Facilities Specializing In Cell Preservation And Cryostorage

Benzinga·03/05/2025 12:07:39
Listen to the news

This Collaboration aims to establish a strategic initiative for stockpiling, distribution, and potential clinical advancement of Pluri's innovative PLX-R18 cell therapy ("PLX-R18") as a countermeasure against Hematopoietic Acute Radiation Syndrome ("H-ARS") in Ukraine. 

Subject to certain conditions, the Collaboration Agreement will be effective for an initial period of three years and can be extended by the parties for an additional period of three years.